Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

The latest news, research updates and announcements from the Nuffield Department of Medicine.

For media enquiries, background information on any of our research, or to arrange interviews with relevant scientists please contact Marin Hirschfeld, NDM Head of Communications. We also have photos and videos of our work available for B-roll purposes.

Subscribe by RSS

What's new

One-third of antibiotics used in Vietnam are ‘inappropriate’

Ranking 11th globally in antibiotic use, Vietnam faces a serious risk of drug resistance, and could be ‘running out of treatment options due to antibiotic resistance’.

RECOVERY trial team win NIHR Impact Prize

Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact.”

Oxford marks World Tuberculosis Day as vaccine trials continue

Thanks to cutting edge research at NDM's Jenner Institute and Oxford University Clinical Research Unit (OUCRU), Oxford remains at the forefront of research to develop new vaccines to protect against this devastating disease.

Lower-dose yellow fever vaccine as effective as the current standard

In a recent study, researchers at the KEMRI Wellcome Trust Research Programme in Kenya have discovered that a low-dose of the yellow fever vaccine is as effective as the current standard dose.

Dr Emilia Antonio

Prioritising research to better address high-consequence outbreaks

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

‘Brain bins’ in neck lymph nodes offer clues about brain health

Scientists have found another clue about how brain health is maintained and how this might be affected by ageing and Alzheimer’s disease, according to a new paper.

New paper outlines ethical issues in clinical metagenomics

Researchers have published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.

Immune response may be harnessed to control HIV

Researchers have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies. New antibody therapies could offer alternative to current treatments.

Africa’s change-makers: meet the new Mastercard Foundation Scholars

The Mastercard Foundation Scholars at Oxford's Africa Oxford Initiative receive full scholarships, rigorous education, leadership training, entrepreneurship support and networking, preparing them to lead Africa's and the world's future challenges and opportunities.

Scientists in a lab

Melanoma progression driven in part by fatty acid uptake

The Goding lab, working in collaboration with the University Rey Juan Carlos, have shown that fatty acid uptake activates an AXL-CAV1-β-catenin axis to drive melanoma invasiveness.

Researcher working in a lab

Study finds previously unidentified genetic determinants of rare disease

A landmark study involving researchers from NDM’s Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.

Doctor looking for tuberculosis in lung scan

Researchers receive funding to develop new therapies for drug-resistant tuberculosis

The Ineos Oxford Institute for antimicrobial research (IOI) has awarded £5 million to a group of interdisciplinary researchers from NDM and other departments at the University, to develop new therapies for drug-resistant tuberculosis.

Health care workers in Bangladesh

Bangladesh malaria vaccine and drug administration trial begins

After more than a year of community engagement and preparation in 100 villages with over 12,000 inhabitants across the Chittagong Hill Tracts, a mass malaria vaccine (R21/Matrix M) and drug administration (DHA, piperaquine, and single low dose primaquine) study was launched on 15 February.

Crowd at a subway station

Advances in AI can help prepare the world for the next pandemic

In the first study of this kind, NDM’s Pandemic Sciences Institute and Oxford researchers partner with global colleagues to outline how artificial intelligence can transform infectious disease research and save more lives.

Chunxiao Song

Chunxiao Song announced as finalist for 2025 UK Blavatnik Awards

Chunxiao Song has been announced as one of nine finalists for the 2025 UK Blavatnik Awards for Young Scientists, in the Chemical Sciences division.

Doctor treating patient

Researchers develop AI-powered tools to improve pneumonia care

A team of researchers at OUCRU was recently awarded a multi-million-dollar Discovery Award from the Wellcome Trust to develop AI tools to advance pneumonia research.

Professor Colin Goding NDM Ludwig Oxford

Colin Goding presented with award from Society for Melanoma Research

Professor Colin Goding of Ludwig Cancer Research Oxford has been named as the 2024 Lifetime Achievement Award by the Society for Melanoma Research.

At home diabetes testing for children

At-home test could play key role in type-1 diabetes screening

A new home test to diagnose type-1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre and NDM's Centre for Human Genetics.

Scientists in a lab

New partnership to advance public health and life science research in West Africa

NDM’s Pandemic Sciences Institute and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Dr Delia O'Rourke, Dr Heba Shawer, Dr Irina Chelysheva, Dr Eoghan Mulholland and Dr Lydia Seed

Five Advance HE fellowships awarded to NDM teaching staff

Five members of the MSc Genomic Medicine teaching team have been awarded Advanced HE fellowships in recognition of their roles in teaching and supporting higher education learning.